Lionheart Health, Inc., operator of Lionheart Longevity & Wellness Clinics, will present its regenerative medicine technology at the 2025 Octane Medical Innovation Forum focused on The Science of Longevity. The forum brings together industry experts, entrepreneurs, investors and thought leaders for discussions on medical industry trends. Howard Leonhardt, Executive Chairman and co-CEO of Lionheart Health, will showcase the company's bioelectric signaling platform that promotes tissue regeneration and longevity.
The company's patented technology utilizes precise bioelectric signaling sequences to trigger the release of regeneration-promoting proteins, including controlled expression of klotho, a protein identified as crucial for aging management. One patented signaling sequence controls stem cell recruitment, proliferation and differentiation on demand. This first-in-class platform represents a significant advancement in regenerative aesthetics and healthspan longevity technologies.
Lionheart Health's business model involves licensing its technology to clinics worldwide within exclusive territories. The company currently operates one clinic in Newport Beach, California, with seven additional licensed locations and plans to expand to 124 licensed sites within the next five years. The company's recognition in the medical innovation field includes being named a top 40 semi-finalist in the XPRIZE Healthspan Competition out of 600 entries, focusing on improvements in muscle health, brain health and immunity health with the goal of increasing healthy living years by 20 years.
Recent accolades include winning recognition from Medtech Outlook Magazine for Top Micro Stimulator Implant Development of 2025 and being a finalist in both the Orange County Business Journal's Innovator of the Year Award and the Octane High Tech Awards in the Medical Innovation category. The company previously won the Abbvie Allergan ULP Golden Passport Award in December 2023 for innovation in medical aesthetics. For more information about the forum where Lionheart will present, visit the event website.
The company's most ambitious project involves developing a whole body regeneration chamber, described as a womb for adults. Current prototypes utilize non-invasive technologies, with future versions planned to incorporate advanced robotics, artificial intelligence, and implantable pump and stimulation technologies for internal organ regeneration. Lionheart Health recently announced a partnership with CoreViva for AI-enhanced MRI diagnostics and maintains long-standing relationships with University Lab Partners and the UCI Beall Applied Innovation Center Prototyping Lab.
Lionheart Health has received multiple UCI Capstone Grants over the years, including one for its Brain Band bioelectric stimulation technology platform for brain health. The company's technology represents a convergence of multiple advanced medical technologies aimed at addressing fundamental aspects of human aging and tissue regeneration. The upcoming presentation at the Octane Medical Innovation Forum provides an opportunity for the medical community to evaluate the potential impact of these technologies on healthspan extension and regenerative medicine practices worldwide.
